Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Reference

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)
include FRENDA results (AMENDA + additional results, but less precise)

Search term:

Results 1 - 10 of 38 > >>
download as CSV
download all results as CSV
EC Number BRENDA No. Title Journal Volume Pages Year Organism PubMed ID
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8754685 Design of new potent HTLV-1 protease inhibitors in silico study Mol. Biol. Res. Commun. 5 19-30 2016 Human T-cell leukemia virus type I 27844017
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8754687 Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors Mol. Biosyst. 11 178-189 2015 Human T-cell leukemia virus type I 25335799
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8754373 Privileged structures meet human T-cell leukemia virus-1 (HTLV-1) C2-symmetric 3,4-disubstituted pyrrolidines as nonpeptidic HTLV-1 protease inhibitors J. Med. Chem. 58 4845-4850 2015 Human T-cell leukemia virus type I 26000468
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8718014 A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network J. Mol. Model. 17 2693-2705 2011 Human T-cell leukemia virus type I 21279524
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8718014 A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network J. Mol. Model. 17 2693-2705 2011 Human T-cell leukemia virus type I Japan ATK-1 subtype A 21279524
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8666190 Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites J. Virol. 79 4213-4218 2005 Human T-cell leukemia virus type I 15767422
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8733682 Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease Comput. Biol. Chem. 56 61-70 2015 Human T-cell leukemia virus type I 25889320
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8678665 Chipping at large, potent human T-cell leukemia virus type 1 protease inhibitors to uncover smaller, equipotent inhibitors Bioorg. Med. Chem. Lett. 17 3276-3280 2007 Human T-cell leukemia virus type I 17448657
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8647854 Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases Eur. J. Biochem. 267 6287-6295 2000 Human T-cell leukemia virus type I 11012683
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.B8647850 Conformational study of a putative HTLV-1 retroviral protease inhibitor Acta Crystallogr. Sect. D 49 344-348 1993 Human T-cell leukemia virus type I 15299523
Results 1 - 10 of 38 > >>
download as CSV
download all results as CSV